Jeffrey W Steaffens

Title: Innovations by Jeffrey W. Steaffens

Introduction

Jeffrey W. Steaffens is an accomplished inventor based in Broomfield, Colorado. He has made significant contributions to the field of flow cytometry, particularly in the evaluation of viral particles. With a total of four patents to his name, his work has advanced the methodologies used in biological research and diagnostics.

Latest Patents

One of his latest patents is titled "Flow cytometry evaluation for unassociated non-enveloped viral particles." This patent describes a method for evaluating non-enveloped viral particles using flow cytometry. The process involves preparing a fluorescently-stained fluid sample, where at least one staining step is performed at an acidic pH. The sample is then subjected to flow cytometry evaluation, enhancing the detection of viral particles.

Another notable patent is "Methods, kits and stain compositions for flow cytometry evaluation of unassociated virus-size particles using multiple fluorogenic dyes." This invention outlines a method for staining fluid samples with multiple fluorogenic dyes. The preparation of the dye formulation includes a concentrated dye mixture that is dissolved in a liquid medium, followed by dilution to create an aqueous solution. This innovative approach allows for improved evaluation of virus-size particles.

Career Highlights

Throughout his career, Jeffrey has worked with reputable companies such as Sartorius Bioanalytical Instruments, Inc. and Essen Instruments, Inc. His experience in these organizations has contributed to his expertise in the field of bioanalytical instruments and flow cytometry.

Collaborations

Jeffrey has collaborated with notable colleagues, including Rebecca K. Montange and Antje Schickert. These partnerships have likely fostered innovation and the exchange of ideas in their respective fields.

Conclusion

Jeffrey W. Steaffens is a prominent inventor whose work in flow cytometry has led to significant advancements in the evaluation of viral particles. His patents reflect a commitment to innovation and excellence in scientific research.